Pharmacokinetics of intravenous voriconazole in patients with liver dysfunction: A prospective study in the intensive care unit

Pharmacokinetics of intravenous voriconazole in patients with liver dysfunction: A prospective study in the intensive care unit

Objectives: To characterize the pharmacokinetics (PK) of intravenous voriconazole (VRC) in critically ill patients with liver dysfunction. Methods: Patients with liver dysfunction in the intensive care unit (ICU) were included prospectively. The Child–Pugh score was used to categorize the degree of...

Full description

Bibliographic Details
Main Authors:	Xiao-bin Lin, Fa Huang, Li Tong, Yan-zhe Xia, Jing-jing Wu, Jia Li, Xiao-guang Hu, Tao Liang, Xiao-man Liu, Guo-ping Zhong, Chang-jie Cai, Xiao Chen
Format:	Article
Language:	English
Published:	Elsevier 2020-04-01
Series:	International Journal of Infectious Diseases
Online Access:	http://www.sciencedirect.com/science/article/pii/S1201971220300990

Similar Items

Safety of intravenous voriconazole in renal failure
by: Abhijit S Nair
Published: (2014-01-01)

Effects of Voriconazole on the Pharmacokinetics of Vonoprazan in Rats
by: Shen J, et al.
Published: (2020-06-01)

Intravenous delivery of a liposomal formulation of voriconazole improves drug pharmacokinetics, tissue distribution, and enhances antifungal activity
by: Danillo F. M. C. Veloso, et al.
Published: (2018-01-01)

Evaluation of intravenous voriconazole in patients with compromised renal function
by: Lilly Craig M, et al.
Published: (2013-01-01)

Pharmacokinetic Drug Interaction between Tofacitinib and Voriconazole in Rats
by: Ji-Sang Lee, et al.
Published: (2021-05-01)

The pharmacokinetic challenge of voriconazole therapy for cerebral aspergillosis in patients treated with ibrutinib
by: Rémy Nyga, et al.
Published: (2019-03-01)

Voriconazole-induced hypokalemia and hyponatremia and their correlations with voriconazole trough concentration
by: CHENG Lin, et al.
Published: (2020-07-01)

Evaluation of the interaction of intravenous and oral voriconazole with oral cyclosporine in iranian HSCT patients
by: Hamidreza Taghvaye Masoumi, et al.
Published: (2017-01-01)

Intravenous Drug Use-Associated Scopulariopsis Endophthalmitis Treated with Systemic and Intravitreal Voriconazole
by: Joseph J. Raevis, et al.
Published: (2018-01-01)

Impact of Albumin and Omeprazole on Steady-State Population Pharmacokinetics of Voriconazole and Development of a Voriconazole Dosing Optimization Model in Thai Patients with Hematologic Diseases
by: Buddharat Khan-asa, et al.
Published: (2020-09-01)

A pharmacokinetic comparison of two voriconazole formulations and the effect of CYP2C19 polymorphism on their pharmacokinetic profiles
by: Chung H, et al.
Published: (2015-05-01)

Predictors of Voriconazole Trough Concentrations in Patients with Child–Pugh Class C Cirrhosis: A Prospective Study
by: Yichang Zhao, et al.
Published: (2021-09-01)

Application of dexmedetomidine with total intravenous anesthesia on perioperative period of carotid endarterectomy
by: Jun CHEN, et al.
Published: (2014-02-01)

Pharmacokinetics of Cyadox and Its Major Metabolites in Swine After Intravenous and Oral Administration
by: Ning ZHAO, et al.
Published: (2013-03-01)

Model based characterization of pharmacokinetic interaction between voriconazole and cytarabine in patients with acute myeloid leukemia
by: Ματθιός, Ανδρέας
Published: (2014)

Development of analytical platforms for the detection of voriconazole-induced liver injury
by: Ting-Yu Wei, et al.
Published: (2014)

Pharmacokinetics of galactose in normal subjects and patients with liver dysfunctions
by: Hu, Teh-Min, et al.
Published: (1993)

Elucidation of Arctigenin Pharmacokinetics and Tissue Distribution after Intravenous, Oral, Hypodermic and Sublingual Administration in Rats and Beagle Dogs: Integration of In Vitro and In Vivo Findings
by: Jie Li, et al.
Published: (2017-06-01)

Pharmacokinetics and Tissue Distribution of Alnustone in Rats after Intravenous Administration by Liquid Chromatography-Mass Spectrometry
by: Yang Song, et al.
Published: (2019-09-01)

Risk of Liver Injury Associated with Intravenous Lipid Emulsions: A Prescription Sequence Symmetry Analysis
by: Xiao-xiao Li, et al.
Published: (2021-03-01)

Clinical Analysis of Intravenous and Oral Sequential Treatment With Voriconazole for Candida Central Nervous System Infection in Six Premature Infants
by: Yingying Zhu, et al.
Published: (2021-06-01)

Pharmacokinetic and Bioavailability Studies of Embelin after Intravenous and Oral Administration to Rats
by: Zhen Li, et al.
Published: (2019-01-01)

Predictors of Adverse Events and Determinants of the Voriconazole Trough Concentration in Kidney Transplantation Recipients
by: Yi‐Chang Zhao, et al.
Published: (2021-03-01)

Voriconazole-induced periostitis
by: D.C. Fernández Ávila, et al.
Published: (2021-04-01)

Serum Voriconazole Level Variability in Patients with Hematological Malignancies Receiving Voriconazole Therapy
by: Lalit Saini, et al.
Published: (2014-01-01)

Liver Dysfunction during Pregnancy and Its Association of With Preterm Birth in China: A Prospective Cohort Study
by: Xun Zhuang, et al.
Published: (2017-12-01)

Pharmacokinetic Study of Perioperative Intravenous Ifosfamide
by: Kurt Van der Speeten, et al.
Published: (2011-01-01)

The intravenous and oral pharmacokinetics of lotilaner in dogs
by: Céline E. Toutain, et al.
Published: (2017-11-01)

The intravenous pharmacokinetics of diminazene in healthy dogs
by: V. Naidoo, et al.
Published: (2009-05-01)

A strategy for designing voriconazole dosage regimens to prevent invasive pulmonary aspergillosis based on a cellular pharmacokinetics/pharmacodynamics model
by: Taotao Wang, et al.
Published: (2018-06-01)

Therapeutic Effect of Intrastromal Voriconazole, Topical Voriconazole, and Topical Natamycin on Fusarium Keratitis in Rabbit
by: Mahmood Nejabat, et al.
Published: (2016-01-01)

Interactive Effects of Glucocorticoids and Cytochrome P450 Polymorphisms on the Plasma Trough Concentrations of Voriconazole
by: Su-jie Jia, et al.
Published: (2021-05-01)

Application of a Physiologically Based Pharmacokinetic Model to Characterize Time-dependent Metabolism of Voriconazole in Children and Support Dose Optimization
by: Yahui Zhang, et al.
Published: (2021-03-01)

Voriconazole-Induced Photosensitivity in Children
by: Nahed Abdel-Haq MD, et al.
Published: (2014-12-01)

Invasive trichosporonosis treated with voriconazole
by: Vaibhav Garg, et al.
Published: (2018-05-01)

Interaction between voriconazole and glimepiride
by: Shobha J, et al.
Published: (2010-01-01)

The pharmacokinetics and pharmacodynamics of intravenous magnesium sulfate in horses
by: Schumacher, Stephen A.
Published: (2019)

The combined utilization of Chlorhexidine and Voriconazole or Natamycin to combat Fusarium infections
by: Tao Jiang, et al.
Published: (2020-09-01)

Pharmacokinetic Model Analysis of Supralingual, Oral and Intravenous Deliveries of Mycophenolic Acid
by: Xiuqing Gao, et al.
Published: (2021-04-01)

Dose recommendations for intravenous colistin in pediatric patients from a prospective, multicenter, population pharmacokinetic study
by: Noppadol Wacharachaisurapol, et al.
Published: (2021-08-01)